Could you take a look at what happened to corgenix conx over the counter.. They sold the company at a very low valuation to a German firm and told the shareholders take it or leave it at 26 cents a share for a total capx of just 13 million dollars. They have the only ebola rapid test kit plus many other products and many ongoing development products plus they actually are currently profitable. In other words they screwed their shareholders. Can you see whats going on behind the scenes?
Thanks much I always read your newsletter email.
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.